Best in Biotech 22 Jan 2025 Curing ALS? Sixteen companies developing new treatments in 2025 …Alchemab Therapeutics (in collaboration with Eli Lilly) Technology: B-cells sequencing Candidates: Multiple antibodies Recent news: Collaboration with Eli Lilly to develop ALS candidates Alchemab Therapeutics is a U.K.-based biopharmaceutical company… January 22, 2025 - 18 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 23 Nov 2017 The Future is (Syn)Bio: How and when do we get there? …process is the lack of a single, common framework to store and access all the data available. “Companies like 23andMe and big pharma like AstraZeneca or Novartis are sequencing the… November 23, 2017 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 28 Nov 2018 Navigating the Rare Disease Space: Insights from a Danish CEO …Hinsby. There is a lot of potential in the orphan disease space. Advances in research and next-generation sequencing over the last decade have revolutionized treatments for rare diseases, many of… November 28, 2018 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 4 Oct 2022 Absolute Biotech launches as unified antibody company …and kits through annotation, validation, sequencing, engineering and recombinant manufacturing. The combined company will leverage each brand’s antibody expertise to advance the creation and availability of life science reagents. Absolute… October 4, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 22 Aug 2022 Hiring practices are shifting as biotech goes digital …CRISPR and gene editing were taking off,” said Wickramasekara. “We had DNA sequencing getting cheaper and new methodologies coming out. There was more automation happening. And we were right at… August 22, 2022 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 18 Feb 2020 OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology …raised an €8M Series A round in 2016. The company has a focus on cancer diagnostic testing — DNA, RNA, and protein profiling and sequencing of both solid tumor biopsies… February 18, 2020 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jul 2022 Mission Bio launches new cancer assay …patients with AML and other cancers. However, these assays are limited to one type of measurement at a time, like flow cytometry for immunophenotyping or bulk sequencing for mutation detection…. July 28, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jul 2023 Camena Bioscience raises $10M for DNA synthesis platform …is the foundation of the synthetic biology value chain, yet developments in DNA synthesis have not kept pace with DNA sequencing and editing capabilities. Camena’s gSynth platform is revolutionizing the… July 4, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Sep 2023 Five latest advancements in NASH research …novel candidate drug targets using the latest technologies, including single-nuclear sequencing of mice and human liver tissue, and advanced 3D glass imaging of mice to characterize key scar-producing liver cells. … September 15, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 10 Jan 2024 The biggest private biotech investments in December 2023 …the healthcare sector, many biotech companies raised big investments to advance technology such as food, biofermentation, and sequencing. In this space, the U.S.’ biggest round went to sequencing firm Parse… January 10, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Sep 2024 Europe’s rising biotech stars: 10 startups to watch in 2024 …formed genomics sequencing company, which is located in England, has come up with a genetic library platform that will aid in drug discovery. Quotient’s somatic genomics platform is designed to… September 26, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Feb 2018 Money, Money, Money! Europe’s Best-Funded Biotechs in 2018 …DNA sequencer, the MinION pocket sequencer, under their belt, UK-based Oxford Nanopore is on track to cause a full-blown revolution in the worldwide nucleic acid sequencing market. With their nanopore… February 20, 2018 - 11 minutesmins - By Karen O’Hanlon Cohrt Share WhatsApp Twitter Linkedin Email